COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,362 Articles (22,803 medRxiv, 8,559 bioRxiv)

Most recent first Previous |  Page 110: Articles 1091-1100  | Next

Dynamics of natural selection preceding human viral epidemics and pandemics.
Havens, J. L., Pond, S. L. K., Zehr, J., Pekar, J. E., Parker, E., Worobey, M., Andersen, K. G., Wertheim, J. O.
10.1101/2025.02.26.640439 — Posted: 2025-02-28
The impact of Intensive Care Strain on Patients Outcomes during COVID-19 - a UNITE COVID study
Kohler, K., De Corte, T., Greco, M., Povoa, P., Cecconi, M., Ostermann, M., De Waele, J., Conway Morris, A., UNITE-COVID investigators
10.1101/2025.02.27.25322947 — Posted: 2025-02-27
Structural and Conformational Impact of Deleterious Spike Protein Mutations in SARS-CoV-2 Omicron Lineages
Khalid, A., Ahmed, K., Kanji, A., Munir, T., Bukhari, A. R., Hasan, Z., Van Voorhis, W., Iqbal, N. T.
10.1101/2025.02.25.639252 — Posted: 2025-02-27
Impact of cell culture model systems on SARS-CoV-2 and MERS-CoV infection dynamics and antiviral responses
Chiok, K., Fenton, M., Falzarano, D., Dhar, N., Banerjee, A.
10.1101/2025.02.24.639954 — Posted: 2025-02-27
Unveiling the Complete Spectrum of SARS-CoV-2 Fusion Stages by In Situ Cryo-ET
Akil, C., Xu, J., Shen, J., zhang, p.
10.1101/2025.02.25.640151 — Posted: 2025-02-27
Changes in somatic symptoms among people with severe COVID anxiety, before and after the coronavirus pandemic
Grocott, L., King, J. D., Mcquaid, A., Leeson, V. C., Crawford, M. J.
10.1101/2025.02.26.25322939 — Posted: 2025-02-26
A truncated SARS-CoV-2 nucleocapsid protein enhances virus fitness by evading antiviral responses
Mulloy, R. P., Evseev, D., Bui-Marinos, M. P., Sharlin, N., Corcoran, J. A.
10.1101/2025.02.15.638421 — Posted: 2025-02-26
Forecasting protein evolution by integrating birth-death population models with structurally constrained substitution models
Ferreiro, D., Gonzalez-Vazquez, L. D., Prado-Comesana, A., Arenas, M.
10.1101/2025.02.21.639428 — Posted: 2025-02-26
Changes in pneumococcal deaths in the United States following the COVID-19 pandemic
Shang, L., Perniciaro, S., Weinberger, D.
10.1101/2025.02.24.25322782 — Posted: 2025-02-25
Pharmacokinetics of anti-SARS-CoV-2 monoclonal antibody SA55 injection in healthy participants
Zhou, Y., MENG, X., Li, J., Wang, J., Zeng, G., Cao, Y. R., Hu, C., Jin, R.
10.1101/2025.02.22.25322730 — Posted: 2025-02-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).